In PRAD, no significant alteration in mRNA expression of NEK1 was observed (Figure 5A), while YAP1 mRNA level was consistently downregulated with respect to the tumor Gleason score (Figure 5B). This evidence concerns the gene NEK1 and prostate adenocarcinoma.